TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce promising results from a program of metallurgical testing undertaken in collaboration with Dundee Sustainable Technologies (“DST”), a subsidiary of Dundee Corporation (TSX: DC.A), to evaluate the effectiveness of DST’s Glasslock Process™ on a high-grade sample from the Joss deposit at the Company’s Beartrack-Arnett Gold Project (“Beartrack-Arnett” or, the “Project”) ...

TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced the appointment of Jane Skoblo as a director of the Company effective August 13, 2025. Ms. Skoblo will serve on both the Audit and Compensation & Organizational Development Committees of Mattr. Ms. Skoblo’s addition to the Board allows for an orderly transition as Laura Cillis, current Director and Audit Committee Chair, intends to retire from the Board at the Company’s next Annual General Meeting. Ms. Sk ...

TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Allied Properties Real Estate Investment Trust ("Allied") (TSX: "AP.UN") today provided an update with respect to pending completion of the final two ground-up developments in its development pipeline: M4 of Main Alley Campus, 108 East Fifth Avenue in Vancouver; and KING Toronto, 489-539 King Street West in Toronto. “Completing the large, multi-city development pipeline we initiated in 2012 has materially enhanced our ability to serve knowledge-based organizations, ...

Thom Lachman and Susan Panuccio Nominated as Independent Non-Executive Directors of the Company Event Registration Available Online at shareholdermeeting.howardhughes.com THE WOODLANDS, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Howard Hughes Holdings (NYSE: HHH) announced today that the company’s Annual Shareholder Meeting will take place on Tuesday, September 30 in New York City. HHH Executive Chairman Bill Ackman and Chief Investment Officer Ryan Israel will discuss the company’s plans to acquire an insura ...

Core Viewpoint - Coppernico Metals Inc. is advancing its Sombrero Project in Peru, focusing on surface exploration results and optimizing land holdings while preparing for Phase 2 drilling [1][3][4]. Exploration and Development - Extensive groundwork has been conducted across the Sombrero land package, leading to the identification of large-scale targets and streamlining of property portfolio to focus on geologically prospective areas [3][4]. - Initial prospect level mapping has been completed at Macha Machay and Milpoc targets, revealing distinct copper-gold hydrothermal alteration zones indicative of epithermal-style systems [6][7][8]. Macha Machay and Milpoc Targets - At Macha Machay, two distinct hydrothermal alteration systems have been identified, with the East prospect showing a broad alteration footprint and geochemical anomalies [7][10]. - The Milpoc target has shown sporadic copper oxide mineralization with historical rock sampling returning copper values up to 8.45% and silver values up to 101 g/t [12][13]. Land Optimization - The company has relinquished 58 claim blocks totaling 50,099 hectares to focus on high-impact targets, reducing the Sombrero Project land position to approximately 53,800 hectares [16]. - This strategic rationalization aims to enhance exploration efficiency and reduce holding costs associated with non-core claims [16]. Future Plans - Coppernico is actively pursuing additional property acquisitions in the U.S. to diversify its project pipeline and enhance exposure to copper and gold assets [4][18]. - The company aims to maintain operational activity and exploration momentum in a mining-friendly jurisdiction while focusing on the Sombrero Project as its core asset [18].

Core Insights - Bitdeer Technologies Group reported a significant increase in Q2 2025 revenue, reaching $155.6 million, which is up 56.8% year-over-year and 121.9% sequentially, driven by growth in self-mining and external sales of SEALMINER A2s [2][3][12] Financial Performance - Total revenue for Q2 2025 was $155.6 million compared to $99.2 million in Q2 2024 [5][10] - Self-mining revenue increased to $59.3 million from $41.6 million, attributed to a 103.3% rise in average self-mining hashrate to 14.2 EH/s [12] - Cloud Hash Rate revenue dropped to $0.0 million from $12.2 million due to the expiration of long-term contracts [12] - General Hosting revenue decreased to $9.3 million from $20.6 million, and Membership Hosting revenue fell to $14.6 million from $22.1 million, both impacted by reduced mining economics post-April 2024 halving [12] - SEALMINER sales generated $69.5 million in revenue [12] Cost and Profitability - Cost of revenue rose to $142.8 million from $74.8 million, primarily due to increased costs associated with SEALMINER sales and higher employee expenses [13] - Gross profit was $12.8 million, down from $24.4 million, resulting in a gross margin of 8.2% compared to 24.6% [20] - Net loss for the quarter was $147.7 million, compared to a loss of $17.7 million in the previous year [16] Operational Highlights - The company is on track to achieve a self-mining hashrate of 40 EH/s by the end of October 2025, with expectations to exceed this target by year-end [3][12] - Year-to-date, Bitdeer has energized 361 MW of datacenter capacity for self-mining, with a total electrical capacity expected to reach over 1.6 GW by year-end [3][12] Research and Development - R&D efforts are focused on the SEALMINER A4 project, targeting a chip efficiency of approximately 5 J/TH [3] - The company has made significant progress in customized silicon software development and expanded its U.S. engineering team to support the SEAL04 chip [3] Cash and Liquidity - As of June 30, 2025, Bitdeer had $299.8 million in cash and cash equivalents and $169.3 million in cryptocurrencies [5][28] - The company reported net cash used in operating activities of $334.9 million, primarily due to payments for SEALMINER wafers and electricity costs [21]

Company Overview - Unicycive Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for kidney diseases [5] - The company's lead investigational treatment is oxylanthanum carbonate, aimed at treating hyperphosphatemia in chronic kidney disease patients on dialysis [5] - The second investigational drug, UNI-494, is intended for treating conditions related to acute kidney injury and has received orphan drug designation from the FDA for preventing Delayed Graft Function in kidney transplant patients [5] Intellectual Property - The U.S. Patent and Trademark Office has issued U.S. Patent 12,377,082 for UNI-494, ensuring intellectual property protection until 2040 [1] - This patent complements an earlier method of use patent for UNI-494 in treating Acute Kidney Injury [1] - The patent portfolio for UNI-494 supports potential partnership opportunities and future development efforts [2] Product Development - UNI-494 is a novel nicotinamide ester derivative that acts as a selective ATP-sensitive mitochondrial potassium channel activator, addressing mitochondrial dysfunction in kidney diseases [3] - The drug has completed a Phase 1 dose-ranging safety study in healthy volunteers [3] - The company is currently focused on seeking FDA approval for its lead product, oxylanthanum carbonate [2] Acute Kidney Injury Context - Acute kidney injury (AKI) is characterized by a sudden loss of kidney function, with primary causes including sepsis, ischemia, and drug-induced nephrotoxicity [4] - AKI affects 20-200 per million in the community, 7-18% of hospitalized patients, and approximately 50% of ICU patients [4] - An estimated 2 million people die from AKI globally each year, with survivors at increased risk for chronic kidney disease and end-stage renal disease [4]

Core Viewpoint - TeraWulf Inc. plans to offer $400 million in convertible senior notes due 2031, subject to market conditions, to qualified institutional buyers [1][10] Group 1: Offering Details - The company may grant initial purchasers an option to buy an additional $60 million in convertible notes within 13 days of the initial issuance [2] - The offering is contingent on market conditions, and there is no assurance regarding its completion [2] - The convertible notes will be senior unsecured obligations, accruing interest payable semi-annually starting March 1, 2026, and maturing on September 1, 2031 [4] Group 2: Use of Proceeds - Net proceeds from the offering will be used to cover costs related to capped call transactions and to finance data center expansion and general corporate purposes [3] Group 3: Conversion Terms - The convertible notes can be converted into cash or a combination of cash and shares of common stock, subject to stockholder approval for an increase in authorized shares [5] - Conversion is restricted until certain conditions are met prior to June 1, 2031, after which it can occur at any time until two trading days before maturity [4][5] Group 4: Capped Call Transactions - The company plans to enter capped call transactions to reduce potential dilution of common stock upon conversion of the notes [6][7] - Initial hedging activities related to these transactions may influence the market price of the common stock and convertible notes [8] Group 5: Company Overview - TeraWulf develops and operates environmentally sustainable data center infrastructure in the U.S., focusing on high-performance computing and bitcoin mining [12]

Group 1 - The suspension of trading in certain departments has been lifted, allowing transactions to resume [1] Group 2 - A list of funds with their respective ISIN and order book codes is provided, indicating the available investment options [2]

Core Insights - Brown & Brown, Inc. has appointed Joia M. Johnson to its board of directors, bringing extensive experience from her previous roles at Hanesbrands Inc. and RARE Hospitality International, Inc. [1][2] Company Overview - Brown & Brown, Inc. is a leading insurance brokerage firm established in 1939, with over 700 locations and a workforce of more than 23,000 professionals [4]. Leadership and Governance - H. Palmer Proctor, Jr., lead independent director, highlighted Johnson's ability to navigate complexity and her experience on various publicly traded boards [2]. - J. Powell Brown, CEO, emphasized that Johnson's unique experience will significantly impact the board and support the company's growth strategy [2]. Joia M. Johnson's Background - Johnson served as Hanes' chief administrative officer from 2016 to 2021 and held multiple leadership roles from 2007 to 2021 [2]. - Prior to her tenure at Hanes, she was executive vice president and general counsel at RARE Hospitality International, Inc. from 2001 to 2007 [2]. Board Memberships - Johnson currently serves on the boards of Global Payments Inc., Sylvamo Corporation, and Regions Financial Corp., holding various committee memberships [3].